Takhzyro Prices, Coupons and Patient Assistance Programs
Takhzyro (lanadelumab) is a member of the miscellaneous coagulation modifiers drug class and is commonly used for Hereditary Angioedema.
The cost for Takhzyro subcutaneous solution (300 mg/2 mL) is around $24,454 for a supply of 2 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Takhzyro price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.Print Free Discount Card
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Takhzyro Coupons and Rebates
Takhzyro offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Takhzyro OnePath Co-Pay Assistance Program: Eligible commercially insured patients may save up to 100% off co-pay expenses; for additional information contact the program at 866-888-0660.
|Number of uses:||Per prescription until program expires|
Patient Assistance Programs for Takhzyro
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: OnePath Patient Assistance Program (TAKHZYRO)Elligibility requirements:
- Determined case by case
- Not disclosed
- Medically appropriate condition/diagnosis
- The patient must also be residing in the US.
- This program provides copay assistance. Education and support services are available; Contact program for details.
- Takhzyro (lanadelumab) Injection; Subcutaneous
More about Takhzyro (lanadelumab)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- En Español
- Drug class: miscellaneous coagulation modifiers
- FDA Approval History